Literature DB >> 33868657

Using LI-RADS With Contrast-Enhanced Ultrasound.

Shuchi K Rodgers1, David T Fetzer2, Yuko Kono3.   

Abstract

Year:  2021        PMID： 33868657      PMCID： PMC8043704          DOI： 10.1002/cld.1077

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  9 in total

1.  Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B Infection.

Authors:  Wei Zheng; Qing Li; Xue-Bin Zou; Jian-Wei Wang; Feng Han; Fei Li; Li-Shu Huang; An-Hua Li; Jian-Hua Zhou
Journal:  Radiology       Date:  2019-11-26       Impact factor: 11.105

2.  CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.

Authors:  D Wildner; T Bernatik; C Greis; K Seitz; M F Neurath; D Strobel
Journal:  Ultraschall Med       Date:  2015-03-26       Impact factor: 6.548

3.  Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.

Authors:  Eleonora Terzi; Massimo Iavarone; Maurizio Pompili; Letizia Veronese; Giuseppe Cabibbo; Mirella Fraquelli; Laura Riccardi; Ludovico De Bonis; Angelo Sangiovanni; Simona Leoni; Maria Assunta Zocco; Sandro Rossi; Nicola Alessi; Stephanie R Wilson; Fabio Piscaglia
Journal:  J Hepatol       Date:  2017-11-11       Impact factor: 25.083

4.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

Review 5.  CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI.

Authors:  Stephanie R Wilson; Andrej Lyshchik; Fabio Piscaglia; David Cosgrove; Hyun-Jung Jang; Claude Sirlin; Christoph F Dietrich; Tae Kyoung Kim; Juergen K Willmann; Yuko Kono
Journal:  Abdom Radiol (NY)       Date:  2018-01

6.  Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Authors:  Ramón Vilana; Alejandro Forner; Luis Bianchi; Angeles García-Criado; Jordi Rimola; Carlos Rodríguez de Lope; María Reig; Carmen Ayuso; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

7.  Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Guang-Jian Liu; Wei Wang; Ming-De Lu; Xiao-Yan Xie; Hui-Xiong Xu; Zuo-Feng Xu; Li-Da Chen; Zhu Wang; Jin-Yu Liang; Yang Huang; Wei Li; Jin-Ya Liu
Journal:  Liver Cancer       Date:  2015-10-21       Impact factor: 11.740

8.  Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.

Authors:  Jia-Yan Huang; Jia-Wu Li; Qiang Lu; Yan Luo; Ling Lin; Yu-Jun Shi; Tao Li; Ji-Bin Liu; Andrej Lyshchik
Journal:  Radiology       Date:  2019-12-03       Impact factor: 11.105

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.